Stay updated on AVOID Trial: Lipegfilgrastim vs Pegfilgrastim in Elderly
Sign up to get notified when there's something new on the AVOID Trial: Lipegfilgrastim vs Pegfilgrastim in Elderly page.

Latest updates to the AVOID Trial: Lipegfilgrastim vs Pegfilgrastim in Elderly page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedAdded site revision tag: Revision: v3.4.2. Removed prior maintenance notices referencing Revision: v3.4.1 (funding status and operating status).SummaryDifference0.3%

- Check17 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center status was added, and the software revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check24 days agoChange DetectedUpdates add a glossary toggle, display the 'Last Update Submitted that Met QC Criteria' field, and change the revision label from v3.3.4 to v3.4.0. Minor capitalization changes to 'No FEAR Act Data' are also applied.SummaryDifference0.2%

- Check31 days agoChange DetectedRemoved administrative metadata and historical sections (e.g., Study Record Dates, Last Verified/Last Update dates, and PubMed publications) from the study record; core trial details, eligibility criteria, locations, and interventions remain accessible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference15%

- Check38 days agoChange DetectedThe page shows a minor update to the revision label, from v3.3.3 to v3.3.4, with no substantive changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedFooter updates show a new 'Revision: v3.3.3' and removal of 'HHS Vulnerability Disclosure' and the prior 'Revision: v3.3.2'. These are minor site maintenance changes and do not affect the study details or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to AVOID Trial: Lipegfilgrastim vs Pegfilgrastim in Elderly
Enter your email address, and we'll notify you when there's something new on the AVOID Trial: Lipegfilgrastim vs Pegfilgrastim in Elderly page.